These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15758699)

  • 81. Integrative tumor board: recently diagnosed prostate cancer.
    Schacht MJ; Saxe GA; Bauer-Wu S; Kennedy S; Monti DA; Peterson C; Rosenberg Z; Block KI
    Integr Cancer Ther; 2003 Mar; 2(1):63-90. PubMed ID: 12941168
    [No Abstract]   [Full Text] [Related]  

  • 82. Clinical diagnosis and staging of prostatic carcinoma.
    Alcini E; D'Addessi A
    Rays; 1993; 18(1):3-13. PubMed ID: 7689236
    [No Abstract]   [Full Text] [Related]  

  • 83. Continued undertreatment of older men with localized prostate cancer.
    Carter HB
    Urology; 2004 Jul; 64(1):189-90; author reply 190. PubMed ID: 15245976
    [No Abstract]   [Full Text] [Related]  

  • 84. [Summary and characteristics of 'General rule for clinical and pathological studies on prostate cancer (the 3rd edition)'].
    Murai M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():39-43. PubMed ID: 12599542
    [No Abstract]   [Full Text] [Related]  

  • 85. Testing for prostate cancer. A consumer view.
    Gardner M
    Aust Fam Physician; 2003 Jun; 32(6):398-9. PubMed ID: 12833762
    [No Abstract]   [Full Text] [Related]  

  • 86. Is it worth diagnosing early prostate cancer?
    Naraynsingh V
    West Indian Med J; 1999 Jun; 48(2):50-1. PubMed ID: 10492601
    [No Abstract]   [Full Text] [Related]  

  • 87. [Why screen for prostate cancer in Finland?].
    Auvinen A; Hakama M; Rannikko S; Stenman UH; Tammela T
    Duodecim; 1996; 112(14):1241-3. PubMed ID: 10596093
    [No Abstract]   [Full Text] [Related]  

  • 88. Summaries for patients. Screening smarter, not harder, for prostate cancer.
    Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
    [No Abstract]   [Full Text] [Related]  

  • 89. Editorial comment.
    Eyre SJ
    J Urol; 2011 Feb; 185(2):488. PubMed ID: 21167520
    [No Abstract]   [Full Text] [Related]  

  • 90. [Problems of prostate cancer in elderly patients].
    Kato H; Nishizawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():304-8. PubMed ID: 12599590
    [No Abstract]   [Full Text] [Related]  

  • 91. Contemporary management of patients with T1a and T1b prostate cancer.
    Capitanio U
    Curr Opin Urol; 2011 May; 21(3):252-6. PubMed ID: 21358335
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lead-time in the European Randomised Study of Screening for Prostate Cancer.
    Finne P; Fallah M; Hakama M; Ciatto S; Hugosson J; de Koning H; Moss S; Nelen V; Auvinen A
    Eur J Cancer; 2010 Nov; 46(17):3102-8. PubMed ID: 21047593
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prostate cancer: to screen or not to screen?
    Bonney R
    Am Clin Lab; 1995 Sep; 14(9):4. PubMed ID: 10158023
    [No Abstract]   [Full Text] [Related]  

  • 94. Patient education. PSA: pros and cons.
    Gattellari M; Ward JE
    Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
    [No Abstract]   [Full Text] [Related]  

  • 95. [Early diagnosis of prostatic cancer in France in 1989].
    Küss R
    An R Acad Nac Med (Madr); 1990; Spec No():13-8. PubMed ID: 1702942
    [No Abstract]   [Full Text] [Related]  

  • 96. [Defect detection using tumor markers].
    Carl P
    Dtsch Med Wochenschr; 2002 Sep; 127(39):2027; author reply 2027-8. PubMed ID: 12395432
    [No Abstract]   [Full Text] [Related]  

  • 97. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.
    Catalona WJ; D'Amico AV; Fitzgibbons WF; Kosoko-Lasaki O; Leslie SW; Lynch HT; Moul JW; Rendell MS; Walsh PC
    Ann Intern Med; 2012 Jul; 157(2):137-8. PubMed ID: 22801676
    [No Abstract]   [Full Text] [Related]  

  • 98. Active surveillance in young patients with prostate cancer: the unanswered question.
    Campodonico F; Maffezzini M
    J Clin Oncol; 2010 May; 28(13):e211; author reply e212. PubMed ID: 20368544
    [No Abstract]   [Full Text] [Related]  

  • 99. Legal implications of prostate cancer: what you should know.
    Reeves JD; Schellhammer PF
    Va Med Q; 1993; 120(2):77-9. PubMed ID: 7683209
    [No Abstract]   [Full Text] [Related]  

  • 100. Prediction models: revolutionary in principle, but do they do more good than harm?
    Vickers AJ
    J Clin Oncol; 2011 Aug; 29(22):2951-2. PubMed ID: 21690474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.